RWM
ROIV icon

Rialto Wealth Management’s Roivant Sciences ROIV Stock Holding History

Rialto Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3K Buy
65
+27
+71% +$798 ﹤0.01% 1070
2026
Q1 		$1.05K Buy
38
+8
+27% +$206 ﹤0.01% 1083
2025
Q4 		$651 Buy
30
+19
+173% +$375 ﹤0.01% 1148
2025
Q3 		$167 Buy
+11
New +$136 ﹤0.01% 1527

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Rialto Wealth Management's ROIV Position: Q2 2026 in Review

Rialto Wealth Management increased its Roivant Sciences (ROIV) stake by 71% in Q2 2026, buying an estimated $798 and bringing the position to 65 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Rialto Wealth Management first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rialto Wealth Management held 65 shares of Roivant Sciences worth $2.3K as of Q2 2026.
  • Rialto Wealth Management bought 27 Roivant Sciences shares in Q2 2026, an estimated $798.
  • Roivant Sciences made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1070 holding.
  • Rialto Wealth Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.